United States · FDA National Drug Code directory

Vivotif

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
50632-016_a53a8319-628e-49b4-98da-fb7dadbca801
Product NDC
50632-016
Form
CAPSULE, COATED
Composition / generic term
Salmonella typhi Ty21a
Labeler
Bavarian Nordic A/S
Marketing category
BLA
Marketing start / end (source format)
20240701
Source listing expiry
20261231

Source-listed ingredients

  • SALMONELLA TYPHI TY21A LIVE ANTIGEN — 6000000000 [CFU]/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BLISTER PACK in 1 CARTON (50632-016-02) / 4 CAPSULE, COATED in 1 BLISTER PACK (50632-016-04) · 50632-016-02

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →